First Light Asset Management, LLC Dynavax Technologies Corp Transaction History

First Light Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $6.24 Million - $13.5 Million	-1,709,541 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $9.66 Million - $16.5 Million	1,364,202 Added 395.03%	1,709,541 $12.5 Million
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $1.64 Million - $2.67 Million	-200,926 Reduced 36.78%	345,339 $3.16 Million
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $29,767 - $40,192	-2,512 Reduced 0.46%	546,265 $6.77 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $1.44 Million - $1.97 Million	95,143 Added 20.97%	548,777 $8.37 Million
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $557,593 - $757,413	38,061 Added 9.16%	453,634 $9.01 Million
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $2.45 Million - $3.41 Million	141,643 Added 51.71%	415,573 $7.77 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $4.16 Million - $5.89 Million	273,930	273,930 $5.89 Million

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.